• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    President, CEO and Chairman Beck Peter converted options into 5,000,000 shares (SEC Form 4)

    6/17/25 7:59:49 PM ET
    $RKLB
    Military/Government/Technical
    Industrials
    Get the next $RKLB alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Beck Peter

    (Last) (First) (Middle)
    C/O ROCKET LAB CORPORATION
    3881 MCGOWEN STREET

    (Street)
    LONG BEACH CA 90808

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Rocket Lab Corp [ RKLB ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director X 10% Owner
    X Officer (give title below) Other (specify below)
    President, CEO and Chairman
    3. Date of Earliest Transaction (Month/Day/Year)
    06/17/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/17/2025 C 5,000,000 A (1)(2)(3) 5,000,000 I By Trust(4)
    Common Stock 789,373 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Series A Convertible Participating Preferred Stock (1)(2) 06/17/2025 C 5,000,000 (1)(2) (1)(2) Common Stock 5,000,000 (1)(2)(3) 45,951,250 I By Trust(4)
    1. Name and Address of Reporting Person*
    Beck Peter

    (Last) (First) (Middle)
    C/O ROCKET LAB CORPORATION
    3881 MCGOWEN STREET

    (Street)
    LONG BEACH CA 90808

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director X 10% Owner
    X Officer (give title below) Other (specify below)
    President, CEO and Chairman
    1. Name and Address of Reporting Person*
    Beck Kerryn

    (Last) (First) (Middle)
    C/O ROCKET LAB CORPORATION
    3881 MCGOWEN STREET

    (Street)
    LONG BEACH CA 90808

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Butler Warren

    (Last) (First) (Middle)
    C/O ROCKET LAB CORPORATION
    3881 MCGOWEN STREET

    (Street)
    LONG BEACH CA 90808

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Equatorial Trust

    (Last) (First) (Middle)
    C/O ROCKET LAB CORPORATION
    3881 MCGOWEN STREET

    (Street)
    LONG BEACH CA 90808

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Peek Street Equatorial Trustee Ltd

    (Last) (First) (Middle)
    C/O ROCKET LAB CORPORATION
    3881 MCGOWEN STREET

    (Street)
    LONG BEACH CA 90808

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. Each share of Series A Convertible Participating Preferred Stock, $0.0001 par value per share ("Series A Preferred Stock"), is convertible into one share of common stock, par value $0.0001 per share ("Common Stock") of the Issuer at any time at the option of the holder, subject to certain adjustments such as in connection with stock dividends, distributions, stock splits and stock combinations.
    2. Each share of Series A Preferred Stock held by the Equatorial Trust (the "Trust"), a family trust settled by Peter Beck and Kerryn Beck, will automatically convert into one share of Common Stock, upon the earliest to occur of (a) the any sale, assignment, transfer, conveyance, hypothecation or other transfer or disposition of such share of Series A Preferred Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation, as amended; (b) the first date on which the Peter Beck shall no longer serve as the Chief Executive Officer or such other executive officer position of the Issuer as approved by its Board of Directors; (c) the death or permanent disability of Peter Beck; or (d) the first date on which the outstanding shares of Series A Preferred Stock no longer represent at least 5% of the beneficial ownership of the Issuer's outstanding Common Stock.
    3. On June 17, 2025, the Trust optionally converted 5,000,000 shares of Series A Preferred Stock into 5,000,000 shares of Common Stock pursuant to the terms of the Series A Preferred Stock Certificate of Designation. The Trust converted the shares for purposes of satisfying delivery of shares of Common Stock to the broker for sales to be made in future months under a Rule 10b5-1 Plan adopted by the Trust on June 13, 2025. The first date that shares are permitted to be sold under the Rule 10b5-1 Plan is September 15, 2025 and the Plan will expire under its terms on December 17, 2025.
    4. These shares are held directly by the Trust. Peek Street Equatorial Trustee Limited (the "Trustee") is the trustee of the Trust and each of Peter Beck, Kerryn Beck and Warren Butler serve as a director of the Trustee with shared voting and investment control of the shares and, as a result, the Trustee and each such individual is deemed to be an indirect beneficial owner of these securities. Each reporting person disclaims beneficial ownership of these securities, except to the extent, if any, of his, her or its pecuniary interest therein, and the filing of this Form 4 is not an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
    /s/ Adam Spice, as Attorney-in-Fact for Peter Beck 06/17/2025
    /s/ Adam Spice, as Attorney-in-Fact for Kerryn Beck 06/17/2025
    /s/ Adam Spice, as Attorney-in-Fact for Warren Butler 06/17/2025
    /s/ Adam Spice, as Attorney-in-Fact for Equatorial Trust 06/17/2025
    /s/ Adam Spice, as Attorney-in-Fact for Peek Street Equatorial Trustee Limited 06/17/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $RKLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RKLB

    DatePrice TargetRatingAnalyst
    4/25/2025$28.00Buy
    Needham
    9/12/2024Mkt Perform
    JMP Securities
    7/15/2024$8.00 → $6.00Overweight → Equal-Weight
    Morgan Stanley
    6/26/2024Neutral
    BTIG Research
    6/11/2024$4.50Neutral
    Goldman
    2/12/2024$6.00Buy
    Citigroup
    1/17/2024$8.00Overweight
    KeyBanc Capital Markets
    10/26/2023$6.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $RKLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham initiated coverage on Rocket Lab USA with a new price target

      Needham initiated coverage of Rocket Lab USA with a rating of Buy and set a new price target of $28.00

      4/25/25 8:32:44 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • JMP Securities initiated coverage on Rocket Lab USA

      JMP Securities initiated coverage of Rocket Lab USA with a rating of Mkt Perform

      9/12/24 9:09:33 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab USA downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Rocket Lab USA from Overweight to Equal-Weight and set a new price target of $6.00 from $8.00 previously

      7/15/24 7:47:38 AM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    SEC Filings

    See more
    • SEC Form 144 filed by Rocket Lab Corporation

      144 - Rocket Lab Corp (0001819994) (Subject)

      6/20/25 4:28:05 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • SEC Form 15-12G filed by Rocket Lab Corporation

      15-12G - Rocket Lab Corp (0001819994) (Filer)

      6/9/25 5:09:09 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • SEC Form 144 filed by Rocket Lab Corporation

      144 - Rocket Lab Corp (0001819994) (Subject)

      6/9/25 4:29:54 PM ET
      $RKLB
      Military/Government/Technical
      Industrials